Physician profile
Jed Willardson
NPI 1578716072
$11,709.01
in general payments reported to CMS, 2019-2025
25 companies · $2,618 in 2025
The $2,618 reported for 2025 was more than what 96% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,049 · 2022: $3,821 · 2023: $2,042 · 2024: $2,179 · 2025: $2,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,442 · Travel and Lodging: $2,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,441.64 |
| Travel and Lodging | $2,397.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $4,017.25 | 2022-2025 | Nalu Neurostimulation System |
| Abbott Laboratories | $3,234.85 | 2021-2025 | Proclaim, Eterna |
| Abbvie INC. | $1,372.03 | 2021-2025 | |
| Boston Scientific Corporation | $1,270.60 | 2021-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $1,015.43 | 2021-2025 | Inceptiv, Synchromedii, Intellis Adaptivestim |
| Nevro Corp. | $100.62 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $87.74 | 2024 | Xeomin |
| Pfizer INC. | $84.77 | 2021-2025 | |
| Saluda Medical Americas, INC. | $78.82 | 2024-2025 | Evoke |
| Merck Sharp & Dohme LLC | $55.10 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $54.34 | 2021 | |
| Biodelivery Sciences International, INC. | $52.64 | 2021 | |
| Scilex Pharmaceuticals INC. | $51.16 | 2021-2023 | Ztlido |
| Amgen INC. | $50.07 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $33.02 | 2024-2025 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $26.08 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.84 | 2025 | Ajovy |
| Axsome Therapeutics, INC. | $16.03 | 2025 | Symbravo |
| Lilly USA, LLC | $14.34 | 2021 | |
| Radius Health, INC. | $14.17 | 2022 | |
| Allergan, INC. | $13.85 | 2022 | |
| Impel Pharmaceuticals INC. | $13.34 | 2023 | Trudhesa |
| Redhill Biopharma INC. | $13.18 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $11.80 | 2021 | |
| Spr Therapeutics, INC | $10.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jed Willardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.